NCT03234023

Brief Summary

DESIGN: Controlled clinical trial with single randomization, unmasked, open and multicentric. CENTERS: University Hospital of A Coruña and University Hospital of Ferrol CONDITION TO STUDY: Acute Coronary Syndrome (ACS). INTERVENTION:monitored outhospital not inhospital supervised. MAIN OBJECTIVE: To determine the incidence of major adverse events (total mortality, new ACS, coronary revascularization, all-cause hospitalization) during the one-year period after hospitalization for ACS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
484

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 31, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2023

Completed
Last Updated

December 9, 2024

Status Verified

December 1, 2024

Enrollment Period

5.4 years

First QC Date

July 25, 2017

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • major adverse events

    total mortality, new ACS, coronary revascularization, hospitalization for any cause

    1 year

Secondary Outcomes (7)

  • cardiovascular mortality

    1 year

  • cardiovascular hospitalization

    one year

  • stroke

    1 year

  • tobacco

    1 year

  • physical activity

    1 year

  • +2 more secondary outcomes

Study Arms (2)

INTERVENTION GROUP

ACTIVE COMPARATOR

The participants of this group will follow recommendations of food, physical exercise, control of consumption of drugs and consumption of alcohol and tobacco.

Behavioral: INTERVENTION GROUP

CONTROL GROUP

NO INTERVENTION

The participants of this group are submitted to the standard intervention.

Interventions

Offer recommendations of healthy living habits and control of pharmacy administration

INTERVENTION GROUP

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages between 18 and 75 years.
  • Patients with ability to read and understand the participation sheet in the study.
  • Patients signing informed consent to participate in the study.
  • Patients living in the health care area of HUAC or HUF.

You may not qualify if:

  • Patients who are dependent for the Basic Activities of Daily Living (BADL) or who suffer from severe cognitive impairment (which makes reliable anamnesis impossible).
  • Patients with a Left Ventricular Ejection Fraction (LVEF) less than or equal to 35%.
  • Patients with a NYHA III / IV score and / or the Canadian Cardiovascular Association (CCS) scale of IV.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital of Ferrol

Ferrol, A Coruña, 15405, Spain

Location

University Hospital of A Coruña

A Coruña, Galicia, 15006, Spain

Location

Related Publications (1)

  • Fernandez-Pombo CN, Aldama-Lopez G, Lorenzo-Carpente M, Lopez-Perez M, Marzoa-Rivas R, Rodriguez-Fernandez JA, Vazquez-Rodriguez JM. A Remote Nursing-Guided Secondary Prevention Programme in Acute Coronary Syndrome. The SPRING Randomised Controlled Trial. J Adv Nurs. 2025 May 15. doi: 10.1111/jan.17046. Online ahead of print.

MeSH Terms

Conditions

Acute Coronary SyndromeMotor Activity

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesBehavior

Study Officials

  • Carmen Neri Fernández Pombo, PhD

    University Hospital A Coruña

    PRINCIPAL INVESTIGATOR
  • Guillermo Aldama López, MD

    University Hospital A Coruña

    PRINCIPAL INVESTIGATOR
  • José Manuel Vázquez Rodríguez, MD

    University Hospital A Coruña

    PRINCIPAL INVESTIGATOR
  • Raquel Marzoa Rivas, MD

    University Hospital Ferrol

    PRINCIPAL INVESTIGATOR
  • Manuel López Pérez, MD

    University Hospital Ferrol

    PRINCIPAL INVESTIGATOR
  • Marta Lorenzo Carpente, Nurse

    University Hospital Ferrol

    PRINCIPAL INVESTIGATOR
  • Jose Angel Rodriguez Fernández, MD

    University Hospital A Coruña

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Nurse.

Study Record Dates

First Submitted

July 25, 2017

First Posted

July 31, 2017

Study Start

October 1, 2017

Primary Completion

February 5, 2023

Study Completion

February 5, 2023

Last Updated

December 9, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

The data of the participants can not be used by other researchers

Locations